(Q33348250)

26 July 2017

CD32-mediated platelet aggregation in vitro by anti-thymocyte globulin: implication of therapy-induced in vivo thrombocytopenia (English)

1 reference

26 July 2017

1 reference

0 references

1 reference

Christoph Buchta

7

0 references

Bernhard Moser

Bernhard Moser

3

0 references

Markus Brunner

Markus Brunner

5

0 references

Georg A. Roth

Georg Alexander Roth

2

0 references

Erika Jensen-Jarolim

Erika Jensen-Jarolim

10

0 references

Hendrik J Ankersmit

1

Hendrik Jan Ankersmit

1 reference

26 July 2017

George Boltz-Nițulescu

12

George Boltz-Nitulescu

1 reference

26 July 2017

Andreas Zuckermann

4

1 reference

26 July 2017

Christiane Rosin

6

1 reference

26 July 2017

Edith Bielek

8

1 reference

26 July 2017

Werner Schmid

9

1 reference

26 July 2017

Ernst Wolner

11

1 reference

26 July 2017

Ivo Volf

13

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

American Journal of Transplantation

26 July 2017

1 reference

26 July 2017

3

1 reference

26 July 2017

6

1 reference

26 July 2017

754-759

1 reference

A quantitative flow cytometry assay for the preclinical testing and pharmacological monitoring of rabbit antilymphocyte globulins (rATG).

26 July 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00150.X

The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00150.X

Long-term follow-up of severe aplastic anaemia patients treated with antithymocyte globulin. Severe Aplastic Anaemia Working Party of the European Cooperative Group for Bone Marrow Transplantation (EBMT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00150.X

7 January 2021

Activation-induced T cell death, and aberrant T cell activation via TNFR1 and CD95-CD95 ligand pathway in stable cardiac transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00150.X

7 January 2021

Improved long-term results with thymoglobuline induction therapy after cardiac transplantation: a comparison of two different rabbit-antithymocyte globulines

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00150.X

7 January 2021

Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00150.X

7 January 2021

A comprehensive definition of the major antibody specificities in polyclonal rabbit antithymocyte globulin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00150.X

7 January 2021

Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00150.X

7 January 2021

Seven years' experience with antilymphoblast globulin for renal transplantation from cadaver donors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00150.X

7 January 2021

A controlled randomized double-blind study of antilymphoblast globulin in cadaver renal transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00150.X

7 January 2021

Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00150.X

7 January 2021

Interaction of two GPIIb/IIIa monoclonal antibodies with platelet Fc receptor (FcγRII)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00150.X

7 January 2021

Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00150.X

7 January 2021

Platelet activation by CD9 monoclonal antibodies is mediated by the Fc gamma II receptor.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00150.X

7 January 2021

10.1034/J.1600-6143.2003.00150.X

Identifiers

DOI

1 reference

26 July 2017

1 reference